The induced interaction results in ubiquitination and subsequent degradation of the recruited protein. Through this mechanism of action molecular glues are not restricted to the agonistic/antagonistic ...

Novartis has accelerated its efforts to develop protein degrader therapies by licensing a prostate cancer candidate from Arvinas on the brink of starting phase 3 trials in a deal worth over $1 ...

Lois Borny works on the product review section of The Independent, IndyBest, where she helps readers to save money and shop savvy, scouting out the very best deals and sharing her tried and tested ...